🔎 Trials Near Me

Почетна › Akutna mijeloidna leukemija › Arizona › Phoenix

Kliničke studije za Akutna mijeloidna leukemija u gradu Phoenix, AZ

13 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Phoenix i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Mayo Clinic Hospital in Arizona, Phoenix
Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Cancer Center at Saint Joseph's, Phoenix
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Тражи се учесникФаза 2
  • Mayo Clinic Hospital in Arizona, Phoenix
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Тражи се учесникФаза 1/2
  • Mayo Clinic Hospital - Phoenix, Phoenix
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05143996

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Тражи се учесникФаза 3
  • Phoenix Childrens Hospital, Phoenix
6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Тражи се учесникФаза 2
  • Mayo Clinic Arizona, Phoenix
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04996875

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Тражи се учесникФаза 1/2
  • Mayo Clinic, Phoenix
Узраст 12 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Тражи се учесникФаза 1/2
  • Phoenix Childrens Hospital, Phoenix
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Тражи се учесникОпсервациона студија
  • Phoenix Children's Hospital, Phoenix
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

Caris Chromoseq Data Collection

Тражи се учесникОпсервациона студија
  • Caris Life Sciences, Phoenix
Узраст 18 и старији · Оба пола · Ажурирано 2. 7. 2026. · NCT07680868

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Тражи се учесникФаза 1
  • Phoenix Children's Hospital, Phoenix
До 21 година · Оба пола · Ажурирано 22. 4. 2026. · NCT05101551

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Тражи се учесникФаза 1/2
  • Mayo Clinic Arizona, Phoenix
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT05732103

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Тражи се учесникФаза 1
  • Mayo Clinic - Phoenix, Phoenix
Узраст 18 и старији · Оба пола · Ажурирано 13. 3. 2026. · NCT05735184

Studije za Akutna mijeloidna leukemija u drugim gradovima

Ostale studije u gradu Phoenix

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.